 ST. PAUL, Minn.BUSINESS WIRECardiovascular Systems, Inc. CSI NASDAQ: CSII, a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the company has initiated the KAIZEN clinical study of its Diamondback 360 Peripheral Orbital Atherectomy System OAS for the treatment of calcified plaque in patients ...... 